These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 6312587

  • 1. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J, Ekoé JM.
    Sem Hop; 1983 Sep 01; 59(29-30):2135-40. PubMed ID: 6312587
    [Abstract] [Full Text] [Related]

  • 2. [Oral antidiabetic agents: recent aspects].
    Keller U, Berger W.
    Schweiz Med Wochenschr; 1983 Apr 30; 113(17):645-50. PubMed ID: 6191388
    [Abstract] [Full Text] [Related]

  • 3. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H, Miller JL, Rose LI.
    Am Fam Physician; 1995 Nov 15; 52(7):2075-8. PubMed ID: 7484707
    [Abstract] [Full Text] [Related]

  • 4. Clinical use of oral hypoglycemic agents.
    Hagg SA.
    Am J Hosp Pharm; 1976 Sep 15; 33(9):943-7. PubMed ID: 790951
    [Abstract] [Full Text] [Related]

  • 5. Oral hypoglycemic agents in the treatment of type II diabetes.
    Tal A.
    Am Fam Physician; 1993 Nov 01; 48(6):1089-95. PubMed ID: 8237731
    [Abstract] [Full Text] [Related]

  • 6. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
    Kolterman OG, Olefsky JM.
    Diabetes Care; 1984 Nov 01; 7 Suppl 1():81-8. PubMed ID: 6376033
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May 01; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Diabetes mellitus under 30 years of age. Results of 18 years experience with oral treatment (author's transl)].
    Mirouze J, Cartry E.
    Diabete Metab; 1975 Jun 01; 1(2):113-8. PubMed ID: 1234068
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sulfonylurea effects on target tissues for insulin.
    McCaleb ML, Maloff BL, Nowak SM, Lockwood DH.
    Diabetes Care; 1984 Jun 01; 7 Suppl 1():42-6. PubMed ID: 6376028
    [Abstract] [Full Text] [Related]

  • 14. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB.
    Journ Annu Diabetol Hotel Dieu; 1984 Jun 01; ():183-91. PubMed ID: 6443219
    [No Abstract] [Full Text] [Related]

  • 15. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J.
    Ther Hung; 1971 Jun 01; 19(2):43-8. PubMed ID: 5172874
    [No Abstract] [Full Text] [Related]

  • 16. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK, Carson DS, Bjelajac A.
    J Fam Pract; 1996 Jun 01; 42(6):612-8. PubMed ID: 8656173
    [Abstract] [Full Text] [Related]

  • 17. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E, Schnell O.
    Diabetes Care; 2008 Feb 01; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract] [Full Text] [Related]

  • 18. [Differential therapy using oral antidiabetics].
    Mehnert H.
    Internist (Berl); 1971 Nov 01; 12(11):468-75. PubMed ID: 4943878
    [No Abstract] [Full Text] [Related]

  • 19. [New aspects of therapy with oral antidiabetic agents].
    Haslbeck M.
    Wien Med Wochenschr; 1979 Dec 30; 199(24):689-95. PubMed ID: 161940
    [No Abstract] [Full Text] [Related]

  • 20. [On the indication and practical use of oral antidiabetics].
    Fankhauser S.
    Schweiz Med Wochenschr; 1972 Jun 17; 102(24):856-62. PubMed ID: 5033624
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.